MHRA has launched a consultation to gain a greater understanding of the potential application of AQbD in pharmacopoeial standards and the future of medicines standards.
Stephen Maddocks
Advertisement
Stephen Maddocks is senior pharmacopoeial scientist at the British Pharmacopoeia.
Articles by Stephen Maddocks
Advertisement
Latest Updated Articles
AQbD, the Evolution of Pharmacopoeial Standards?Published: July 17th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360 2025: Trends in Bioanalysis
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
